GNRH1 and cancer: Standard protocols depend on spontaneous menstruations and include GnRH (gonadotropin-releasing hormone) agonists to lower the hyperstimulation syndrome, but commonly used stimulation protocols in the context of cancer emergency preservation now use GnRH antagonists to reduce procedure duration [68].